Insulet Corp. Company Profile (NASDAQ:PODD)

About Insulet Corp.

Insulet Corp. logoInsulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin delivery system for people with insulin-dependent diabetes. The OmniPod System consists of the OmniPod, a small, self-adhesive disposable tubeless OmniPod device, which is worn on the body for approximately three days at a time and its wireless handheld Personal Diabetes Manager (PDM). The Company purchases OmniPods pursuant to its agreement with Flextronics. It also partners with pharmaceutical and biotechnology companies to tailor the OmniPod technology platform for the delivery of subcutaneous drugs across multiple therapeutic areas. It sells the OmniPod System and other diabetes management supplies in the United States through direct sales to customers or through its distribution partners. The Company purchases OmniPods pursuant to its agreement with Flextronics. The OmniPod System is available in Europe, Canada and Israel.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: PODD
  • CUSIP: 45784P10
Key Metrics:
  • Previous Close: $40.66
  • 50 Day Moving Average: $41.32
  • 200 Day Moving Average: $35.88
  • 52-Week Range: $23.94 - $45.60
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -218.94
  • P/E Growth: -3.64
  • Market Cap: $2.25B
  • Outstanding Shares: 57,267,000
  • Beta: 1.23
  • Net Margins: -17.68%
  • Return on Equity: -137.88%
  • Return on Assets: -18.16%
  • Debt-to-Equity Ratio: 6.40%
  • Current Ratio: 3.29%
  • Quick Ratio: 2.84%
Additional Links:
Companies Related to Insulet Corp.:

Analyst Ratings

Consensus Ratings for Insulet Corp. (NASDAQ:PODD) (?)
Ratings Breakdown: 8 Hold Ratings, 8 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $40.92 (3.84% upside)

Analysts' Ratings History for Insulet Corp. (NASDAQ:PODD)
DateFirmActionRatingPrice TargetDetails
10/2/2016B. RileyInitiated CoverageNeutral$46.00View Rating Details
8/17/2016JPMorgan Chase & Co.Reiterated RatingHold$38.00View Rating Details
8/16/2016Piper Jaffray Cos.Reiterated RatingOverweight$52.00View Rating Details
8/5/2016Canaccord GenuityReiterated RatingHold$36.00View Rating Details
8/4/2016Leerink SwannReiterated RatingOutperform$40.00 -> $50.00View Rating Details
8/4/2016Jefferies GroupBoost Price TargetBuy$41.00 -> $45.00View Rating Details
8/4/2016WedbushBoost Price TargetOutperform$44.00 -> $48.00View Rating Details
7/12/2016BTIG ResearchInitiated CoverageNeutralView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingNeutralView Rating Details
4/29/2016William BlairUpgradeMarket Perform -> OutperformView Rating Details
2/26/2016Feltl & Co.UpgradeHold -> Buy$35.00View Rating Details
2/26/2016Benchmark Co.UpgradeHold -> Buy$30.00 -> $40.00View Rating Details
2/22/2016Robert W. BairdLower Price TargetNeutral$35.00 -> $30.00View Rating Details
1/7/2016Cowen and CompanyBoost Price Target$40.00View Rating Details
12/3/2015Northland SecuritiesReiterated RatingMarket PerformView Rating Details
11/2/2015Morgan StanleyInitiated CoverageEqual -> Equal Weight$32.00View Rating Details
5/1/2015Oppenheimer Holdings Inc.Lower Price TargetMarket Perform$33.00 -> $31.00View Rating Details
1/15/2015Raymond James Financial Inc.DowngradeOutperform -> Market PerformView Rating Details
11/6/2014JMP SecuritiesReiterated RatingMarket Outperform$9.00 -> $10.00View Rating Details
11/4/2014Northcoast ResearchInitiated CoverageNeutralView Rating Details
(Data available from 10/25/2014 forward)


Earnings History for Insulet Corp. (NASDAQ:PODD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/3/2016Q216($0.17)($0.08)$81.10 million$87.30 millionViewN/AView Earnings Details
4/28/2016Q116($0.19)($0.19)$79.06 million$81.21 millionViewListenView Earnings Details
2/25/2016Q415($0.26)($0.48)$91.89 million$100.10 millionViewListenView Earnings Details
11/5/2015Q315($0.26)($0.33)$83.56 million$87.30 millionViewListenView Earnings Details
8/12/2015Q215($0.13)($0.27)$70.32 million$75.60 millionViewListenView Earnings Details
4/30/2015Q115($0.10)($0.21)$68.20 million$61.20 millionViewN/AView Earnings Details
2/26/2015Q414($0.04)($0.10)$73.52 million$72.60 millionViewN/AView Earnings Details
8/7/2014Q214($0.08)($0.06)$72.94 million$72.00 millionViewN/AView Earnings Details
5/7/2014Q114($0.06)($0.11)$68.47 million$69.20 millionViewN/AView Earnings Details
2/27/2014Q413($0.09)($0.04)$67.94 million$68.53 millionViewN/AView Earnings Details
11/7/2013Q313($0.16)($0.39)$62.01 million$61.10 millionViewN/AView Earnings Details
8/7/2013Q2 2013($0.19)($0.20)$60.47 million$60.09 millionViewN/AView Earnings Details
5/6/2013Q1 2013($0.21)($0.20)$57.26 million$57.40 millionViewN/AView Earnings Details
2/27/2013Q4 2012($0.21)($0.21)$59.12 million$57.80 millionViewN/AView Earnings Details
11/8/2012Q312($0.22)($0.26)$54.93 million$54.80 millionViewN/AView Earnings Details
8/8/2012($0.25)($0.30)ViewN/AView Earnings Details
5/9/2012($0.28)($0.31)ViewN/AView Earnings Details
2/9/2012($0.26)($0.30)ViewN/AView Earnings Details
11/3/2011($0.25)($0.29)ViewN/AView Earnings Details
8/2/2011($0.21)($0.42)ViewN/AView Earnings Details
5/9/2011($0.22)($0.22)ViewN/AView Earnings Details
2/15/2011($0.26)($0.50)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Insulet Corp. (NASDAQ:PODD)
Current Year EPS Consensus Estimate: $-0.44 EPS
Next Year EPS Consensus Estimate: $-0.18 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.29)($0.29)($0.29)
Q2 20163($0.21)($0.14)($0.18)
Q3 20167($0.09)($0.04)($0.08)
Q4 20168($0.10)($0.05)($0.07)
Q1 20174($0.10)($0.02)($0.07)
Q2 20174($0.05)$0.00($0.03)
Q3 20174($0.04)$0.02($0.01)
Q4 20174$0.01$0.03$0.02
Q1 20181$0.06$0.06$0.06
Q2 20181$0.10$0.10$0.10
(Data provided by Zacks Investment Research)


Dividend History for Insulet Corp. (NASDAQ:PODD)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Insulet Corp. (NASDAQ:PODD)
Insider Ownership Percentage: 1.90%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/25/2016Regina O SommerDirectorSell8,019$30.42$243,937.98View SEC Filing  
5/18/2016Patrick J SullivanCEOBuy45,000$27.00$1,215,000.00View SEC Filing  
5/13/2016Bradley A ThomasEVPBuy2,975$26.63$79,224.25View SEC Filing  
5/5/2016Bradley A ThomasEVPBuy1,656$30.13$49,895.28View SEC Filing  
3/10/2016Daniel J LevangieInsiderSell12,299$30.89$379,916.11View SEC Filing  
3/7/2016Daniel J LevangieInsiderSell7,663$31.15$238,702.45View SEC Filing  
3/2/2016Jessica HopfieldDirectorBuy3,230$30.91$99,839.30View SEC Filing  
6/5/2015Patrick J SullivanCEOBuy10,000$29.39$293,900.00View SEC Filing  
5/28/2015Patrick J SullivanCEOBuy20,000$27.91$558,200.00View SEC Filing  
5/15/2015Timothy J ScannellDirectorBuy3,500$27.05$94,675.00View SEC Filing  
5/5/2015Bradley A ThomasEVPBuy1,000$27.26$27,260.00View SEC Filing  
5/5/2015Patrick RyanCOOBuy3,669$26.99$99,026.31View SEC Filing  
4/2/2015R Anthony DiehlGeneral CounselSell3,372$30.96$104,397.12View SEC Filing  
3/9/2015Patrick J SullivanCEOBuy10,000$31.93$319,300.00View SEC Filing  
3/2/2015Charles T LiamosDirectorSell4,000$32.00$128,000.00View SEC Filing  
2/12/2015Charles T LiamosDirectorSell4,000$32.00$128,000.00View SEC Filing  
1/2/2015Charles T LiamosDirectorSell4,000$46.08$184,320.00View SEC Filing  
11/3/2014Charles T LiamosDirectorSell4,000$42.95$171,800.00View SEC Filing  
10/1/2014Charles T LiamosDirectorSell4,000$36.58$146,320.00View SEC Filing  
10/1/2014R Anthony DiehlGeneral CounselSell1,250$36.59$45,737.50View SEC Filing  
9/10/2014Charles T LiamosDirectorSell4,000$35.17$140,680.00View SEC Filing  
9/2/2014Duane DesistoCEOSell20,000$36.30$726,000.00View SEC Filing  
8/1/2014Duane DesistoCEOSell20,000$34.23$684,600.00View SEC Filing  
7/1/2014Duane DesistoCEOSell20,000$40.52$810,400.00View SEC Filing  
7/1/2014R Anthony DiehlGeneral CounselSell1,250$39.65$49,562.50View SEC Filing  
6/11/2014R Anthony DiehlGeneral CounselSell17,871$37.09$662,835.39View SEC Filing  
6/9/2014Peter DevlinInsiderSell12,314$37.10$456,849.40View SEC Filing  
4/8/2014Peter DevlinInsiderSell30,000$41.25$1,237,500.00View SEC Filing  
4/3/2014R Anthony DiehlGeneral CounselSell4,617$48.67$224,709.39View SEC Filing  
3/6/2014R Anthony DiehlGeneral CounselSell12,458$49.28$613,930.24View SEC Filing  
3/6/2014Tracey Haas WielinskiVPSell8,275$49.21$407,212.75View SEC Filing  
2/3/2014Charles LiamosDirectorSell11,037$42.93$473,818.41View SEC Filing  
2/3/2014Duane DesistoCEOSell20,000$42.95$859,000.00View SEC Filing  
2/3/2014Peter DevlinInsiderSell30,000$42.82$1,284,600.00View SEC Filing  
1/3/2014Charles LiamosCOOSell86,000$36.02$3,097,720.00View SEC Filing  
1/2/2014Duane DesistoCEOSell20,000$36.07$721,400.00View SEC Filing  
12/3/2013Charles LiamosCOOSell63,808$36.26$2,313,678.08View SEC Filing  
11/18/2013Charles LiamosCOOSell80,000$35.60$2,848,000.00View SEC Filing  
9/3/2013Duane DesistoCEOSell20,000$33.38$667,600.00View SEC Filing  
8/29/2013Sally CrawfordDirectorSell9,000$33.42$300,780.00View SEC Filing  
8/15/2013Regina SommerDirectorSell5,000$33.32$166,600.00View SEC Filing  
8/1/2013Duane DesistoCEOSell20,000$31.85$637,000.00View SEC Filing  
7/1/2013Duane DesistoCEOSell20,000$31.51$630,200.00View SEC Filing  
7/1/2013Peter DevlinInsiderSell30,000$31.48$944,400.00View SEC Filing  
6/14/2013Sally CrawfordDirectorSell31,000$30.47$944,570.00View SEC Filing  
6/10/2013R Anthony DiehlGeneral CounselSell38,455$30.50$1,172,877.50View SEC Filing  
6/3/2013Duane DesistoCEOSell20,000$29.76$595,200.00View SEC Filing  
12/3/2012Brian K RobertsCFOSell10,000$21.92$219,200.00View SEC Filing  
11/1/2012Brian K RobertsCFOSell10,000$21.49$214,900.00View SEC Filing  
9/4/2012Brian K RobertsCFOSell10,000$20.78$207,800.00View SEC Filing  
9/4/2012Duane DesistoCEOSell20,000$20.97$419,400.00View SEC Filing  
9/4/2012Ruthann DepietroVPSell1,000$20.90$20,900.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Insulet Corp. (NASDAQ:PODD)
DateHeadline logoInsulet (PODD) CEO Sullivan Named Chairman; Other Exec Changes Made (NASDAQ:PODD) - October 20 at 7:07 PM logoInsulet Corporation (NASDAQ:PODD) Files An 8-K (NASDAQ:PODD) - October 20 at 7:07 PM logoINSULET CORP Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial State (NASDAQ:PODD) - October 20 at 8:13 AM logoInsulet Announces Board and Management Changes (NASDAQ:PODD) - October 20 at 8:13 AM
News IconUpdate on Insulet Corporation (NASDAQ:PODD) for the day (NASDAQ:PODD) - October 15 at 11:34 AM featured highlights: Insulet, Cliffs Natural Resources, NVIDIA, Ultra Petroleum and Pan American Silver (NASDAQ:PODD) - October 13 at 6:58 PM logoInsulet Corporation (NASDAQ:PODD) Mean Rating At $1.94 (NASDAQ:PODD) - October 9 at 6:08 PM logoInsulet Corp. – Value Analysis (NASDAQ:PODD) : October 3, 2016 (NASDAQ:PODD) - October 3 at 6:23 PM logoInsulet Shares Up 27.3% Since SmarTrend's Buy Recommendation (PODD) (NASDAQ:PODD) - September 30 at 3:22 PM logoInsulet Corp. breached its 50 day moving average in a Bearish Manner : PODD-US : September 30, 2016 (NASDAQ:PODD) - September 30 at 3:22 PM logoInsulet Corporation to Announce Third Quarter 2016 Financial Results on November 3, 2016 (NASDAQ:PODD) - September 27 at 6:42 PM logoFirst Week of November 18th Options Trading For Insulet (PODD) (NASDAQ:PODD) - September 24 at 6:09 PM logoInsulet Up 40.6% Since SmarTrend Uptrend Call (PODD) (NASDAQ:PODD) - September 22 at 11:39 AM logoUptrend Call Working As Insulet Stock Rises 27.6% (PODD) (NASDAQ:PODD) - September 14 at 6:57 PM
News IconInsulet closes $345 private placement (NASDAQ:PODD) - September 14 at 6:57 PM
News IconInsulet Enrolls First Patients In Clinical Trial For Its Omnipod Artificial Pancreas System (NASDAQ:PODD) - September 14 at 6:57 PM logoINSULET CORP Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Shee (NASDAQ:PODD) - September 14 at 11:12 AM logoInsulet Corporation (PODD) - Financial and Strategic SWOT Analysis Review - New Report Available (NASDAQ:PODD) - September 13 at 11:42 AM logoResearch Analysts Set Insulet Corporation (NASDAQ:PODD)’s Price Target At $43.477 (NASDAQ:PODD) - September 13 at 11:42 AM logoInsulet (PODD) Announces Enrollment of First Patient in Omnipod Horizon System Study (NASDAQ:PODD) - September 13 at 11:42 AM logoInsulet Enrolls First Patients in Clinical Trial for its Omnipod ® Artificial Pancreas System (NASDAQ:PODD) - September 13 at 11:42 AM logoInsulet Enrolls First Patients in Clinical Trial for its Omnipod® Artificial Pancreas System (NASDAQ:PODD) - September 13 at 11:42 AM logoInsulet Announces Pricing of Convertible Senior Notes Due 2021 (NASDAQ:PODD) - September 8 at 10:41 AM logo3:17 am Insulet upsizes offering by $50 mln and prices $300 mln of 1.25% convertible senior notes due 2021 (NASDAQ:PODD) - September 8 at 10:41 AM logoBRIEF-Insulet announces pricing of convertible senior notes due 2021 (NASDAQ:PODD) - September 7 at 9:00 PM logoInsulet (PODD) to Offer $250M in Convertible Senior Notes (NASDAQ:PODD) - September 7 at 6:59 PM logoINSULET CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:PODD) - September 6 at 6:56 PM logoInsulet Announces Private Offering of Convertible Senior Notes (NASDAQ:PODD) - September 6 at 6:56 PM logoBRIEF-Insulet announces private offering of convertible senior notes (NASDAQ:PODD) - September 6 at 5:39 PM logoInsulet to Establish Highly-Automated Manufacturing Operation in the United States (NASDAQ:PODD) - September 6 at 11:36 AM logoInsulet Announces Executive Appointments (NASDAQ:PODD) - September 6 at 11:36 AM logoPrice Target For Insulet Corporation (NASDAQ:PODD) Set At $43.022 By Research Analysts (NASDAQ:PODD) - September 4 at 10:52 AM logoINSULET CORP Files SEC form 8-K, Entry into a Material Definitive Agreement (NASDAQ:PODD) - September 1 at 6:49 PM logoINSULET CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Rights of Secur (NASDAQ:PODD) - September 1 at 9:58 AM logoWill Insulet (PODD) Crush Estimates at Its Next Earnings Report? (NASDAQ:PODD) - September 1 at 9:58 AM logoETF’s with exposure to Insulet Corp. : September 1, 2016 (NASDAQ:PODD) - September 1 at 9:58 AM logoUptrend Call Working As Insulet Stock Rises 35.8% (PODD) (NASDAQ:PODD) - August 30 at 6:47 PM logoInsulet (PODD): Field Checks Indicate Longer Term Upside - Piper Jaffray (NASDAQ:PODD) - August 16 at 7:00 PM logoMoving Average Crossover Alert: Insulet (PODD) (NASDAQ:PODD) - August 16 at 7:00 PM logoCan The Uptrend Continue for Insulet (PODD)? (NASDAQ:PODD) - August 15 at 7:14 PM logoInsulet A Buy On Raised Growth Forecasts (NASDAQ:PODD) - August 11 at 7:23 PM logoINSULET CORP Financials (NASDAQ:PODD) - August 11 at 7:23 PM logoETF’s with exposure to Insulet Corp. : August 9, 2016 (NASDAQ:PODD) - August 9 at 7:09 PM logoInsulet Corp. :PODD-US: Earnings Analysis: Q2, 2016 By the Numbers : August 8, 2016 (NASDAQ:PODD) - August 8 at 7:07 PM logoInsulet Corp. (PODD) Surged To A New High After Guidance Increase (NASDAQ:PODD) - August 5 at 9:57 AM logoInsulet Reaches Analyst Target Price (NASDAQ:PODD) - August 5 at 9:57 AM logoInsulet Corp. (PODD) Has Broken Out To A New High After Q2 Loss (NASDAQ:PODD) - August 4 at 7:24 PM logoINSULET CORP Files SEC form 10-Q, Quarterly Report (NASDAQ:PODD) - August 4 at 7:24 PM logoWhy Insulet Corporation Shares Are Soaring 19.5% Today (NASDAQ:PODD) - August 4 at 1:13 PM logoInsulet Delivers Healthy Q2 Revenue Growth; Stock Pumps Up Nearly 9% (NASDAQ:PODD) - August 4 at 11:37 AM


Insulet Corp. (NASDAQ:PODD) Chart for Tuesday, October, 25, 2016

Last Updated on 10/25/2016 by Staff